Please complete the CAPTCHA to continue
@biogen.com
✓
1 phone found area 847
✓
LinkedIn matched
A concise factual answer block for searchers comparing this professional profile.
Jeremy Graff is listed as SVP, Global Head of Rare Disease at Biogen at Biogen, based in Cambridge, Massachusetts, United States. AeroLeads shows a work email signal at biogen.com, phone signal with area code 847, and a matched LinkedIn profile for Jeremy Graff.
Jeremy Graff previously worked as Senior Vice President, Global Head of Rare Disease Franchise at Biogen and Senior Vice President, Global Head of Neuromuscular Disease Franchise at Biogen. Jeremy Graff holds Bachelor Of Science - Bs, Engineering from Cornell University.
This section adds company-level context without repeating Jeremy Graff's masked contact details.
AeroLeads found 1 current-domain work email signal for Jeremy Graff. Compare company email patterns before reaching out.
P&L Leader with a successful track record of developing and launching blockbuster medicines in the biopharmaceutical industry. Deep expertise in leading teams through areas spanning new product launch, brand turnaround, product management, business development and product life-cycle extension. Experienced in:Biologics | Orphan & Rare Disease | Buy and Bill | Specialty Injectables | Marketing | Marketing Strategy | Sales | DTC | DTP | Digital | Managed Care | Global Market Access | Global Commercial Development | Trade | Distribution | Pricing | Life-Cycle ManagementDirect accountability for leadership across functions including:R&D | Medical Affairs | CMC | Regulatory Affairs | Manufacturing Operations | Finance | HR | ComplianceTherapeutic Area Experience Across:Rheumatology | Immunology | Dermatology | Nephrology | Podiatry | Endocrinology | Arthritis | Inflammation | Women’s Health | Gynecology | Neuropathic and Nociceptive Pain | Anesthesia | Ophthalmology | Gastroenterology | Cardiology | Infectious Disease | Neurology | Neuroscience | Neuromuscular Disease
Listed skills include Pharmaceutical Industry, Product Launch, Rheumatology, Strategy, and 41 others.
Company context helps verify the profile and gives searchers a useful next step.
A career timeline built from the work history available for this profile.
Cambridge, Ma, Us
Responsible for therapeutic area inclusive of SMA, ALS, Friedreich's Ataxia and other rare diseases. Portfolio of products include SPINRAZA, QALSODY, SKYCLARYS and investigational assets BIIB105, BIIB115. Completed Business Development transactions including acquisition of Reata Pharmaceuticals, Inc., Licensing / Option Agreements with Alcyone Therapeutics and Ionis Pharmaceuticals, Inc.
Cambridge, Ma, Us
Responsible for therapeutic area inclusive of SMA, ALS and other neuromuscular diseases
Cambridge, Ma, Us
Global responsibility for SMA and SPINRAZA (nusinersen) across all functions including R&D, Medical Affairs, Commercial, Market Access and Manufacturing.
Dublin, Ireland, Ie
Led Horizon's Rheumatology Business Unit, including the relaunch of KRYSTEXXA (pegloticase), an IV administered biologic medicine indicated for an orphan, rare disease* Prior to its Jan, 2016 acquisition by Horizon, KRYSTEXXA’s underperformance led Savient Pharmaceuticals ($18M revenue) to file bankruptcy* KRYSTEXXA become Horizon’s flagship medicine and its largest selling product by 2Q 2018 * Annual Net Sales grew to $259M by 2018 (CAGR of +60%) * Horizon revised projections (on three occasions), ultimately targeting peak annual sales beyond $1B
North Chicago, Illinois, Us
Commercial lead for Women's Health portfolio including elagolix (ORILISSA)* Responsible for P&L, all commercial functions to inform product’s development and launch * Substantially revised the sales potential in lead indication * Negotiated investment in a second indication, driving progression of the program from Ph1 to Ph3 despite emergence of a potent competitor and changes to product profile* Responsible for global marketing strategy, positioning, geographic focus, target claims, and payer value
Abbott Park, Illinois, Us
Delivered value as an innovative commercial leader for the formative launch years for HUMIRA, a product that ultimately delivered annual sales exceeding $19B. Supported the launch across five marketing roles with expanding responsibilities. Experience spanned multiple indication launches, novel devices, and expansion to additional specialties.
New York, New York, Us
Supported COX-2 portfolio of Celebrex and Bextra
Quick answers generated from the profile data available on this page.
Jeremy Graff works for Biogen.
Jeremy Graff is listed as SVP, Global Head of Rare Disease at Biogen at Biogen.
AeroLeads has found 1 work email signal at @biogen.com for Jeremy Graff at Biogen.
AeroLeads has found 1 phone signal(s) with area code 847 for Jeremy Graff at Biogen.
Jeremy Graff is based in Cambridge, Massachusetts, United States while working with Biogen.
Jeremy Graff has worked for Biogen, Scipher Medicine, Horizon, Abbvie, and Abbott.
You can use AeroLeads to view verified contact signals for Jeremy Graff at Biogen, including work email, phone, and LinkedIn data when available.
Jeremy Graff holds Bachelor Of Science - Bs, Engineering from Cornell University.
Jeremy Graff is listed with skills including Pharmaceutical Industry, Product Launch, Rheumatology, Strategy, Immunology, Dermatology, Commercialization, and Pipeline Development.
Search by job title, company, industry, location, and seniority. Export verified B2B contact data when you need it.
Start free trial Search contacts